Viewing Study NCT02921035


Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2026-02-28 @ 3:31 AM
Study NCT ID: NCT02921035
Status: COMPLETED
Last Update Posted: 2022-04-04
First Post: 2016-09-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing Multiple Sclerosis (RMS) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsing Multiple Sclerosis View
None Interferon beta-1a View
None Rebif® View
None Morisky Green Levine Medication Adherence Scale View